Crinetics Pharmaceuticals (CRNX) EBITDA Margin Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,609.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Crinetics Pharmaceuticals | 3.75 Bn | 3.75 Bn | 10.53 Mn | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.53 Mn |
| Jun 30, 2025 | 739,241.00 |
| Mar 31, 2025 | -1.59 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | -892,305.00 |
| Sep 30, 2023 | -690,594.00 |
| Jun 30, 2023 | 489,974.00 |
| Mar 31, 2023 | -50,023.00 |
| Dec 31, 2022 | -330,260.00 |
| Dec 31, 2021 | -3.34 Mn |
| Dec 31, 2020 | 3.51 Mn |
| Mar 31, 2020 | -2.20 Mn |
| Dec 31, 2019 | -346,808.00 |
| Sep 30, 2019 | -147,988.00 |
| Mar 31, 2019 | -119,759.00 |
| Dec 31, 2018 | -60,622.00 |
| Sep 30, 2018 | -101,373.00 |
| Jun 30, 2018 | -65,001.00 |